Other OTC • Healthcare • Biotechnology • DK • USD
Orphazyme A/S (ORPHY) and trades at $0.03.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-0.74.
The stock has a beta of 0.00, operates in the Healthcare sector.
Be the first to know when stocks drop below their intrinsic value.
